Black phosphorus nanosheets enhance differentiation of neural progenitor cells for improved treatment in spinal cord injury
© 2023 Elsevier Ltd. All rights reserved.Abstract
Stem cell transplantation holds great potential as a treatment option for nerve damage diseases. However, the therapeutic effects are significantly impeded by low survival rate and uncontrolled differentiation of stem cells. In this study, black phosphorus nanosheets (BPNs), which are biodegradable inorganic nanomaterials, are first revealed with remarkable abilities to regulate cellular redox homeostasis, enhance transplant survival rate of stem cells, and facilitate neural differentiation of neural progenitor cells (NPCs). These effects of BPNs are proved to be associated with the activation of nuclear factor erythroid 2-like 2 (Nrf2) pathways in NPCs. In vivo, BPNs-treated NPCs could effectively inhibit inflammatory response and neuronal apoptosis in the mice with spinal cord injury (SCI). In addition, BPNs-treated NPCs more effectively reduce glial scar formation and promote axon regeneration compared with natural NPCs in SCI site. These findings collectively support the therapeutic potentials of BPNs for advanced stem cell transplantation and neural tissue engineering in the future.
Highlights:
• Black phosphorus nanosheets (BPNs) promote differentiation of neural progenitor cells (NPCs)
• BPNs promote neural differentiation of NPCs via the activation of Nrf2 pathway.
• BPNs promote NPCs neural differentiation by regulating cellular redox homeostasis.
• BPNs-treated NPCs reduce glial scar formation and promote axon regeneration.
Supplementary Information can be accessed here.
Ke Cheng, PhD
I am a chemical biologist with expertise in organic chemistry, bioconjugation, protein biology, and oncology. My research focuses on developing small molecule probes and drugs, antibody drug conjugates, and radioligand agents for targeted cancer therapy, including the design of cleavable ADC linkers and next generation payloads, as well as tumor activatable probes and chemoproteomics driven target discovery.